9078 Subset analysis of a phase III trial comparing two platinum-based doublets: i.v./Oral vinorelbine (NVB) vs docetaxel (DTX): impact of histology on response and survival in advanced Non-Small Cell Lung Cancer (NSCLC)

E.Tan

首页> 外文期刊>European Journal of Cancer Supplements >9078 Subset analysis of a phase III trial comparing two platinum-based doublets: i.v./Oral vinorelbine (NVB) vs docetaxel (DTX): impact of histology on response and survival in advanced Non-Small Cell Lung Cancer (NSCLC)

【24h】

9078 Subset analysis of a phase III trial comparing two platinum-based doublets: i.v./Oral vinorelbine (NVB) vs docetaxel (DTX): impact of histology on response and survival in advanced Non-Small Cell Lung Cancer (NSCLC)

机译：9078期III期试验的亚组分析，比较了两种基于铂的双联体：静脉/长春瑞滨（NVB）与多西他赛（DTX）：组织学对晚期非小细胞肺癌（NSCLC）的反应和生存的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
E.Tan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献

1. 6501 ORAL Global Lung Oncology Branch trial 3 (GLOB 3): Quality of Life (QoL) results of a randomised multinational Phase III trial of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced non-small cell lung cancer (NSCLC) [J] . J.Rolski, T.Grodzki, C.P.Schneider, European Journal of Cancer Supplements . 2007,第4期

机译：6501 ORAL全球肺肿瘤科试验3（GLOB 3）：一项针对口服和静脉注射的跨国多国III期随机试验的生活质量（QoL）结果。长春瑞滨（NVB）加顺铂（CDDP）与多西他赛（DTX）加CDDP作为晚期非小细胞肺癌（NSCLC）的一线治疗
2. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial. [J] . Bennouna J, Senellart H, Hiret S, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2011,第1期

机译：组织学对接受辅助化疗的切除的非小细胞肺癌（NSCLC）生存的影响：长春瑞滨（NVB）顺铂（CDDP）辅助治疗的亚组分析与ANITA试验的观察结果。
3. 6521 POSTER Is pemetrexed more effective in patients with non-squamous histology? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC) [J] . P.Peterson, K.Park, F.Fossella, European Journal of Cancer Supplements . 2007,第4期

机译：6521海报培美曲塞对非鳞状组织学患者是否更有效？培美曲塞与多西他赛III期试验在先前治疗的晚期非小细胞肺癌（NSCLC）患者中的回顾性分析
4. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, -1

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
5. PD4-2-3: Global Lung Oncology Branch trial 3 (Glob 3): final results of a randomised multinational Phase III study of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced Non-Small Cell Lung Cancer (NSCLC) [O] . Tan Eng-Huat, Grodzki Tomasz, Schneider Claus-Peter, 2007

机译：PD4-2-3：全球肺肿瘤科试验3（Glob 3）：一项针对口服和静脉注射的跨国多国III期随机研究的最终结果长春瑞滨（NVB）加顺铂（CDDP）与多西他赛（DTX）加CDDP作为晚期非小细胞肺癌（NSCLC）的一线治疗

9078 Subset analysis of a phase III trial comparing two platinum-based doublets: i.v./Oral vinorelbine (NVB) vs docetaxel (DTX): impact of histology on response and survival in advanced Non-Small Cell Lung Cancer (NSCLC)

著录项

相似文献

相关主题

期刊订阅